Dellon_et_al_DDW_May_2020
Loading viewer...
report
Format: PDF report
This report presents findings from the ENIGMA trial, highlighting histologic and symptomatic improvements in eosinophilic gastrointestinal diseases treated with Antolimab.
Loading viewer...
report
Format: PDF report
This report presents findings from the ENIGMA trial, highlighting histologic and symptomatic improvements in eosinophilic gastrointestinal diseases treated with Antolimab.
presentation
report
Ligand Pharmaceuticals
report
Delta Corporation
report
Denny's Corporation
report
LMG
